Herein, we will focus on vascular endothelial growth factor (VEGF) and VEGF receptor (VEFR) inhibitors, proteasome and Immune Checkpoint inhibitors (ICIs) and their interplay with myocardial tolerance against IRI and cardiovascular diseases. This evidence concerns the gene VEGFA and cardiovascular disorder.